CytomX Therapeutics (CTMX) Provides Business Update and Outlines 2023 Goals
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/24/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
| Eaton Vance Dividend Builder Fd Cl C (NASDAQ: CTMX) | Delayed: 2.32 -0.12 (4.92%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.44 | 52 Week High | $24.68 | |||
| Open | $2.41 | 52 Week Low | $9.10 | |||
| Day High | $2.42 | P/E | N/A | |||
| Day Low | $2.31 | EPS | $0.00 | |||
| Volume | 4,365,989 | |||||
